Profile data is unavailable for this security.
About the company
Fidson Healthcare Plc is a Nigeria-based pharmaceutical manufacturing company. The principal activities of the Company include manufacturing and distribution of pharmaceutical products. The Company's segments include over-the-counter, ethical products, and consumer healthcare. The over-the-counter segment represents the products that may be sold directly to the consumer without a prescription. The ethical products segment represents drugs, injectables and infusions, which will be sold to the consumer only on the possession of a valid prescription. The consumer segment represents manufacturing products for customers. It provides services, including formulation/development, contract manufacturing, and production of medicines. Its products include Anti-Infective and Anti-Malaria, Central Nervous System, Gastrointestinal Medicines, Topical/Dermatological Medicines, Vitamins and Minerals, Ophthalmic Solution, among others. Its Ophthalmic Solution helps manage and treat eye conditions.
- Revenue in NGN (TTM)60.53bn
- Net income in NGN3.28bn
- Incorporated1995
- Employees650.00
- LocationFidson Healthcare PLC268, Ikorodu Road, ShomoluP.O.Box 7210LAGOS NigeriaNGA
- Phone+234 3429102
- Fax+234 3429106
- Websitehttps://www.fidson.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Devonian Health Group Inc | 11.76bn | -3.82bn | 28.59bn | 6.00 | -- | 1.78 | -- | 2.43 | -0.0216 | -0.0216 | 0.0665 | 0.09 | 0.4423 | 33.07 | 2.32 | 1,625,238.00 | -14.37 | -21.02 | -23.15 | -23.96 | 30.95 | 29.96 | -32.50 | -131.97 | 1.06 | -9.41 | 0.1406 | -- | 1.74 | -5.83 | -33.39 | -- | -- | -- |
| Lasa Supergenerics Ltd | 20.47bn | -3.82bn | 29.02bn | 77.00 | -- | -- | -- | 1.42 | -3.92 | -3.92 | 20.94 | -- | -- | -- | -- | 13,586,300.00 | -- | -3.86 | -- | -5.34 | 26.41 | 32.53 | -18.65 | -5.30 | -- | -4.49 | -- | -- | -19.47 | -9.26 | 43.73 | -- | -- | -- |
| Cilo Cybin Holdings Ltd | -9.31tn | -9.31tn | 29.10bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 182.51 | -- | -- | -- |
| Nexgel Inc | 8.21bn | -5.55bn | 29.40bn | 19.00 | -- | 4.02 | -- | 3.58 | -0.5722 | -0.5722 | 0.8464 | 0.6589 | 0.4942 | 3.03 | 6.44 | 263,631.60 | -35.74 | -44.61 | -48.15 | -56.19 | 23.74 | 5.02 | -72.33 | -180.98 | 0.8135 | -- | 0.1992 | -- | 99.66 | 13.06 | 33.48 | -- | -- | -- |
| Cumberland Pharmaceuticals, Inc. | 61.94bn | -17.01bn | 29.57bn | 91.00 | -- | 0.6841 | -- | 0.4775 | -0.7328 | -0.7328 | 2.67 | 1.87 | 0.4501 | 0.8643 | 3.17 | 415,225.80 | -12.35 | -7.03 | -17.75 | -9.52 | 82.58 | 79.95 | -27.45 | -17.64 | 1.26 | -38.85 | 0.382 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
| IX Biopharma Ltd | 7.53bn | -13.64bn | 30.14bn | 56.00 | -- | 4.78 | -- | 4.00 | -0.014 | -0.014 | 0.0077 | 0.0057 | 0.3013 | 4.20 | 1.99 | -- | -54.58 | -39.79 | -86.37 | -52.71 | 17.59 | 50.67 | -181.14 | -150.87 | 0.7053 | -2.31 | 0.5451 | -- | 0.778 | 54.77 | -12.26 | -- | -29.94 | -- |
| Oncimmune Holdings PLC | 2.62bn | -6.77bn | 30.15bn | 33.00 | -- | -- | -- | 11.51 | -0.0423 | 0.0958 | 0.0164 | -0.0172 | 0.1756 | 1.19 | 0.6917 | 36,787.88 | -45.43 | -- | -- | -- | 63.34 | -- | -258.65 | -- | 1.01 | -0.6511 | 1.32 | -- | -- | -- | -- | -- | -- | -- |
| Fidson Healthcare PLC | 60.53bn | 3.28bn | 30.18bn | 650.00 | 8.93 | 1.35 | 6.52 | 0.4986 | 1.47 | 1.47 | 26.92 | 9.75 | 1.09 | 2.19 | 8.92 | 93,123,760.00 | 5.92 | 7.96 | 11.61 | 13.32 | 39.41 | 43.22 | 5.42 | 8.37 | 0.6794 | 1.74 | 0.5908 | 32.58 | 30.56 | 26.73 | -13.84 | -- | 53.26 | 34.49 |
| Cyclo Therapeutics Inc | 1.86bn | -33.99bn | 30.58bn | 8.00 | -- | -- | -- | 16.47 | -0.9104 | -0.9104 | 0.0474 | -0.1785 | 0.242 | 0.4002 | 13.16 | 141,553.80 | -443.08 | -132.22 | -- | -215.17 | 91.56 | 90.37 | -1,831.29 | -1,114.04 | 0.4283 | -- | -- | -- | -21.76 | 1.25 | -29.81 | -- | -3.95 | -- |
| Vaidya Sane Ayurved Laboratories Ltd | 20.45bn | 710.24m | 30.86bn | 632.00 | 43.40 | 2.88 | 23.68 | 1.51 | 3.46 | 3.46 | 99.55 | 52.12 | 1.74 | 11.90 | 20.17 | 1,654,093.00 | 6.04 | -- | 7.39 | -- | 71.79 | -- | 3.47 | -- | 2.57 | 16.25 | 0.0683 | -- | 32.55 | -- | 49.62 | -- | -- | -- |
| Medipharm Labs Corp | 45.52bn | -16.26bn | 32.21bn | 166.00 | -- | 0.5611 | -- | 0.7076 | -0.0378 | -0.0378 | 0.1033 | 0.1158 | 0.5662 | 2.75 | 3.82 | 227,451.80 | -20.22 | -32.88 | -24.86 | -39.56 | 23.80 | -5.88 | -35.72 | -67.66 | 2.33 | -- | 0.0557 | -- | 49.49 | 26.52 | 56.37 | -- | -49.66 | -- |
